Glovadalen

N/A

Report date: 2025/04/30 16:58:10
NME

Base Information

Drug NameGlovadalen
Drug Alias NameUCB-0022
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D1 receptor modulators
TargetsDopamine D1 receptor
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUcb Biopharma Srl
China Registration ClassN/A

Develop Information

Active CompaniesUcb Biopharma Srl
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A